{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:31:30Z","timestamp":1791225090992,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Microbiology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.mib.2011.07.030","type":"journal-article","created":{"date-parts":[[2011,8,21]],"date-time":"2011-08-21T17:36:33Z","timestamp":1313948193000},"page":"532-543","source":"Crossref","is-referenced-by-count":161,"title":["New target for inhibition of bacterial RNA polymerase: \u2018switch region\u2019"],"prefix":"10.1016","volume":"14","author":[{"given":"Aashish","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meliza","family":"Talaue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Degen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard Y","family":"Ebright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Sineva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirban","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey Y","family":"Druzhinin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujoy","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanta","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yon W","family":"Ebright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Zozula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui Rong","family":"Niedfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takushi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Irschik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Donadio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H","family":"Ebright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mib.2011.07.030_bib0005","first-page":"600","article-title":"Bacterial RNA polymerase: a promising target for the discovery of new antimicrobial agents","volume":"8","author":"Chopra","year":"2007","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.mib.2011.07.030_bib0010","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.drudis.2007.01.005","article-title":"Progress in targeting bacterial transcription","volume":"12","author":"Villain-Guillot","year":"2007","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.mib.2011.07.030_bib0015","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2174\/092986709787315559","article-title":"Bacterial RNA polymerase inhibitors: an organized overview of their structure, derivatives, biological activity and current clinical development status","volume":"16","author":"Mariani","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.mib.2011.07.030_bib0020","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.sbi.2009.10.010","article-title":"Structures of RNA polymerase\u2013antibiotic complexes","volume":"19","author":"Ho","year":"2009","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.mib.2011.07.030_bib0025","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1021\/cr030112j","article-title":"Rifamycin: mode of action, resistance, and biosynthesis","volume":"105","author":"Floss","year":"2005","journal-title":"Chem Rev"},{"key":"10.1016\/j.mib.2011.07.030_bib0030","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0092-8674(01)00286-0","article-title":"Structural mechanism for rifampicin inhibition of bacterial RNA polymerase","volume":"104","author":"Campbell","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.mib.2011.07.030_bib0035","first-page":"796","article-title":"Role of individual drugs in the chemotherapy of tuberculosis","volume":"4","author":"Mitchison","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.mib.2011.07.030_bib0040","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1001\/jama.286.20.2549","article-title":"Clinical presentation of inhalational anthrax following bioterrorism exposure: report of two surviving patients","volume":"286","author":"Mayer","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.mib.2011.07.030_bib0045","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1001\/jama.286.18.2226","article-title":"Update: investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001","volume":"286","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.mib.2011.07.030_bib0050","unstructured":"Ebright R: RNA exit channel: target and method for inhibition of bacterial RNA polymerase. WO2005\/001034; 2005."},{"key":"10.1016\/j.mib.2011.07.030_bib0055","unstructured":"Ebright R: Switch region: target and method for inhibition of bacterial RNA polymerase. WO2007\/094799; 2007."},{"key":"10.1016\/j.mib.2011.07.030_bib0060","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.cell.2008.09.033","article-title":"The RNA polymerase \u201cswitch region\u201d is a target for inhibitors","volume":"135","author":"Mukhopadhyay","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.mib.2011.07.030_bib0065","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature07510","article-title":"Transcription inactivation through local refolding of the RNA polymerase structure","volume":"45","author":"Belogurov","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.mib.2011.07.030_bib0070_1","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1038\/emboj.2010.135","article-title":"The transcription inhibitor lipiarmycin blocks DNA fitting into the RNA polymerase catalytic site","volume":"29","author":"Tupin","year":"2010","journal-title":"EMBO J"},{"key":"10.1016\/j.mib.2011.07.030_bib0075","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cell.2008.09.052","article-title":"Inhibiting RNA polymerase","volume":"135","author":"Sousa","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.mib.2011.07.030_bib0080","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2217\/17460913.4.2.145","article-title":"Myxopyronin: a punch in the jaws of bacterial RNA polymerase","volume":"4","author":"Tupin","year":"2009","journal-title":"Future Microbiol"},{"key":"10.1016\/j.mib.2011.07.030_bib0085","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1002\/anie.200900338","article-title":"Inhibition of RNA polymerase","volume":"48","author":"Haebich","year":"2009","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.mib.2011.07.030_bib0090","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1126\/science.1059493","article-title":"Structural basis of transcription: RNA polymerase II at 2.8\u00c5 resolution","volume":"292","author":"Cramer","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.mib.2011.07.030_bib0095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0959-440X(02)00294-4","article-title":"Multisubunit RNA polymerases","volume":"12","author":"Cramer","year":"2002","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.mib.2011.07.030_bib0100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0167-4781(02)00451-7","article-title":"Elongation by RNA polymerase II: structure\u2013function relationship","volume":"1577","author":"Gnatt","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.mib.2011.07.030_bib0105","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.molcel.2004.11.040","article-title":"Complete RNA polymerase II elongation complex structure and its interactions with NTP and TFIIS","volume":"16","author":"Kettenberger","year":"2004","journal-title":"Mol Cell"},{"key":"10.1016\/j.mib.2011.07.030_bib0110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature05932","article-title":"Structural basis for transcription elongation by bacterial RNA polymerase","volume":"448","author":"Vassylyev","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.mib.2011.07.030_bib0115_1","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1093\/nar\/gkq355","article-title":"Multiple roles of the RNA polymerase \u03b2\u2032 SW2 region in transcription initiation, promoter escape, and RNA elongation","volume":"38","author":"Pupov","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.mib.2011.07.030_bib0120","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.7164\/antibiotics.36.1651","article-title":"The myxopyronins, new inhibitors of bacterial RNA synthesis from Myxococcus fulvus (Myxobacterales)","volume":"36","author":"Irschik","year":"1983","journal-title":"J Antibiot"},{"key":"10.1016\/j.mib.2011.07.030_bib0125","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/jlac.198319831003","article-title":"Antibiotics from gliding bacteria. XVII. Myxopyronin A and B \u2013 two novel antibiotics from Myxococcus fulvus strain Mx f50","volume":"1983","author":"Kohl","year":"1983","journal-title":"Liebigs Ann Chem"},{"key":"10.1016\/j.mib.2011.07.030_bib0130","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/jlac.198419840605","article-title":"Antibiotics from gliding bacteria. XXII. Biosynthesis of myxopyronin A, an antibiotic from Myxococcus fulvus, strain Mx f50","volume":"1984","author":"Kohl","year":"1984","journal-title":"Liebigs Ann Chem"},{"key":"10.1016\/j.mib.2011.07.030_bib0135","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1021\/jo9721610","article-title":"Total synthesis and preliminary antibacterial evaluation of the RNA polymerase inhibitors (+\/\u2212)-Myxopyronin A and B","volume":"63","author":"Hu","year":"1998","journal-title":"J Org Chem"},{"key":"10.1016\/j.mib.2011.07.030_bib0140","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1128\/AAC.44.11.3163-3166.2000","article-title":"RNA polymerase inhibitors with activity against rifampin-resistant mutants of Staphylococcus aureus","volume":"44","author":"O\u2019Neill","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mib.2011.07.030_bib0145","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1574-6968.2011.02282.x","article-title":"Evaluating the activity of the RNA polymerase inhibitor myxopyronin B against Staphylococcus aureus","volume":"319","author":"Moy","year":"2011","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.mib.2011.07.030_bib0150","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1128\/AAC.46.11.3381-3385.2002","article-title":"Biological cost of rifampin resistance from the perspective of Staphylococcus aureus","volume":"46","author":"Wichelhaus","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mib.2011.07.030_bib0155","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/AAC.50.1.298-309.2006","article-title":"Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence","volume":"50","author":"O\u2019Neill","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mib.2011.07.030_bib0160","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1128\/AAC.43.8.1866","article-title":"Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis","volume":"43","author":"Billington","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mib.2011.07.030_bib0165","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1126\/science.1124410","article-title":"The competitive cost of antibiotic resistance in Mycobacterium tuberculosis","volume":"312","author":"Gagneux","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.mib.2011.07.030_bib0170","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1016\/j.bmcl.2004.08.045","article-title":"Myxopyronin B analogs as inhibitors of RNA polymerase, synthesis and biological evaluation","volume":"14","author":"Doundoulakis","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.mib.2011.07.030_bib0175","doi-asserted-by":"crossref","first-page":"6797","DOI":"10.1016\/j.bmcl.2007.10.017","article-title":"Syntheses of novel myxopyronin B analogs as potential inhibitors of bacterial RNA polymerase","volume":"17","author":"Lira","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.mib.2011.07.030_bib0180_1","doi-asserted-by":"crossref","unstructured":"Saecker R, Record MJ, Dehaseth P: Mechanism of bacterial transcription initiation: RNA polymerase-promoter binding, isomerization to initiation-competent open complexes, and initiation of RNA synthesis. J Mol Biol 2011, In Press.","DOI":"10.1016\/j.jmb.2011.01.018"},{"key":"10.1016\/j.mib.2011.07.030_bib0185","doi-asserted-by":"crossref","first-page":"145","DOI":"10.7164\/antibiotics.38.145","article-title":"The corallopyronins, new inhibitors of bacterial RNA synthesis from Myxobacteria","volume":"38","author":"Irschik","year":"1985","journal-title":"J Antibiot"},{"key":"10.1016\/j.mib.2011.07.030_bib0190","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1128\/AAC.01742-10","article-title":"Activity and development of resistance to corallopyronin A, an inhibitor of RNA polymerase","volume":"55","author":"Mariner","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mib.2011.07.030_bib0195","unstructured":"Wardenga G: Enwicklung eines synthetischen Zugangs zu potentiellen Antibiotika auf Basis der Naturstoffs Corallopyronin A. Thesis, Gottfried Wilhelm Leibniz Universit\u00e4t, Hannover, Germany; 2007."},{"key":"10.1016\/j.mib.2011.07.030_bib0200_1","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/cbic.201000085","article-title":"Biosynthesis of the Myxobacterial antibiotic corallopyronin A","volume":"11","author":"Erol","year":"2010","journal-title":"Chembiochem"},{"key":"10.1016\/j.mib.2011.07.030_bib0205","doi-asserted-by":"crossref","first-page":"787","DOI":"10.7164\/antibiotics.48.787","article-title":"The ripostatins, novel inhibitors of eubacterial RNA polymerase isolated from myxobacteria","volume":"48","author":"Irschik","year":"1995","journal-title":"J Antibiot"},{"key":"10.1016\/j.mib.2011.07.030_bib0210","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/jlac.199619961026","article-title":"Antibiotics from gliding bacteria. Part LXXVIII. Ripostatin A, B, and C. Isolation and structure elucidation of novel metabolites from Sorangium cellulosum","volume":"10","author":"Augustiniak","year":"1996","journal-title":"Liebigs Ann Chem"},{"key":"10.1016\/j.mib.2011.07.030_bib0215","unstructured":"Kujat C: Studien zur Totalsynthese von Ripostatin A & B. Thesis, Gottfried Wilhelm Leibniz Universit\u00e4t, Hannover, Germany; 2007."},{"key":"10.1016\/j.mib.2011.07.030_bib0220","unstructured":"Schleicher K: Nickel-catalyzed preparation of acrylamides from alpha olefins and isocyanates; synthetic studies toward ripostatin A. Thesis, Massachusetts Institute of Technology; 2010."},{"key":"10.1016\/j.mib.2011.07.030_bib0235","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7164\/antibiotics.28.247","article-title":"Lipiarmycin, a new antibiotic from Actinoplanes. I. Description of the producer strain and fermentation studies","volume":"28","author":"Parenti","year":"1975","journal-title":"J Antibiot"},{"key":"10.1016\/j.mib.2011.07.030_bib0240","doi-asserted-by":"crossref","first-page":"253","DOI":"10.7164\/antibiotics.28.253","article-title":"Lipiarmycin, a new antibiotic from Actinoplanes. II. Isolation, chemical, biological and biochemical characterization","volume":"28","author":"Coronelli","year":"1975","journal-title":"J Antibiot"},{"key":"10.1016\/j.mib.2011.07.030_bib0245","doi-asserted-by":"crossref","first-page":"543","DOI":"10.7164\/antibiotics.28.543","article-title":"Lipiarmycin, a new antibiotic from Actinoplanes. III. Mechanism of action","volume":"1975","author":"Sergio","year":"1975","journal-title":"J Antibiot"},{"key":"10.1016\/j.mib.2011.07.030_bib0250","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0006-291X(75)80047-7","article-title":"Lipiarmycin: an antibiotic inhibiting nucleic acid polymerases","volume":"63","author":"Talpaert","year":"1975","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.mib.2011.07.030_bib0255","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.7164\/antibiotics.39.1407","article-title":"Clostomicins, new antibiotics produced by Micromonospora echinospora subsp. armeniaca subsp. nov. I. Production, isolation, and physico-chemical and biological properties","volume":"39","author":"Omura","year":"1986","journal-title":"J Antibiot"},{"key":"10.1016\/j.mib.2011.07.030_bib0260","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1039\/p19870001353","article-title":"Structure elucidation of the macrocyclic antibiotic lipiarmycin","volume":"6","author":"Arnone","year":"1987","journal-title":"J Chem Soc Perkin Trans I"},{"key":"10.1016\/j.mib.2011.07.030_bib0265","doi-asserted-by":"crossref","first-page":"567","DOI":"10.7164\/antibiotics.40.567","article-title":"Tiacumicins, a novel complex of 18-membered macrolide antibiotics. I. Taxonomy, fermentation and antibacterial activity","volume":"40","author":"Theriault","year":"1987","journal-title":"J Antibiot"},{"key":"10.1016\/j.mib.2011.07.030_bib0270","doi-asserted-by":"crossref","first-page":"575","DOI":"10.7164\/antibiotics.40.575","article-title":"Tiacumicins, a novel complex of 18-membered macrolides. II. Isolation and structure determination","volume":"40","author":"Hochlowski","year":"1987","journal-title":"J Antibiot"},{"key":"10.1016\/j.mib.2011.07.030_bib0275","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1358\/dof.2006.031.06.1000709","article-title":"Tiacumicin B","volume":"31","author":"Revill","year":"2006","journal-title":"Drugs Future"},{"key":"10.1016\/j.mib.2011.07.030_bib0280","first-page":"168","article-title":"Drug evaluation: OPT-80, a narrow-spectrum macrocyclic antibiotic","volume":"8","author":"Johnson","year":"2007","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.mib.2011.07.030_bib0285","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1517\/13543784.17.4.547","article-title":"OPT-80, a macrocyclic antimicrobial agent for the treatment of Clostridium difficile infections: a review","volume":"17","author":"Gerber","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.mib.2011.07.030_bib0295","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1517\/14656566.2010.485614","article-title":"Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection","volume":"11","author":"Miller","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.mib.2011.07.030_bib0300","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2217\/fmb.10.20","article-title":"Fidaxomicin: a new macrocyclic, RNA polymerase-inhibiting antibiotic for the treatment of Clostridium difficile infections","volume":"5","author":"Poxton","year":"2010","journal-title":"Future Microbiol"},{"key":"10.1016\/j.mib.2011.07.030_bib0400","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1586\/eri.11.53","article-title":"Fidaxomicin: first-in-class macrocyclic antibiotic","volume":"9","author":"Mullane","year":"2011","journal-title":"Expert Rev Anti-Infective Ther"},{"key":"10.1016\/j.mib.2011.07.030_bib0305","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/JB.132.1.73-79.1977","article-title":"Lipiarmycin-resistant ribonucleic acid polymerase mutants of Bacillus subtilis","volume":"132","author":"Sonenshein","year":"1977","journal-title":"J Bacteriol"},{"key":"10.1016\/j.mib.2011.07.030_bib0310","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-2836(79)90459-5","article-title":"Initiation of transcription in vitro inhibited by lipiarmycin","volume":"127","author":"Sonenshein","year":"1979","journal-title":"J Mol Biol"},{"key":"10.1016\/j.mib.2011.07.030_bib0315","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1128\/AAC.35.6.1108","article-title":"In vitro and in vivo evaluation of tiacumincins B and C against Clostrdium difficile","volume":"35","author":"Swanson","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mib.2011.07.030_bib0320","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1128\/AAC.48.6.2280-2282.2004","article-title":"In vitro activity of OPT-80 against Clostridium difficile","volume":"48","author":"Ackermann","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mib.2011.07.030_bib0325","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/jac\/dkn269","article-title":"Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis","volume":"62","author":"Kurabachew","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mib.2011.07.030_bib0330","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ijantimicag.2009.07.003","article-title":"Frequency and characterisation of spontaneous lipiarmycin-resistant Enterococcus faecalis mutants selected in vitro","volume":"34","author":"Gualtieri","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.mib.2011.07.030_bib0335","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1128\/AAC.50.1.401-402.2006","article-title":"Mutation in the Bacillus subtilis RNA polymerase beta\u2032 subunit confers resistance to lipiarmycin","volume":"50","author":"Gualtieri","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mib.2011.07.030_bib0340_1","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection","volume":"364","author":"Louie","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mib.2011.07.030_bib0345_1","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.2146\/news110046","article-title":"Fidaxomicin approved for C. difficile infections","volume":"68","author":"Traynor","year":"2011","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.mib.2011.07.030_bib0350_1","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1021\/ja109445q","article-title":"Characterization of tiacumicin B biosynthetic gene cluster affording diversified tiacumicin analogues and revealing a tailoring dihalogenase","volume":"133","author":"Xiao","year":"2011","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.mib.2011.07.030_bib0355","doi-asserted-by":"crossref","first-page":"201","DOI":"10.7164\/antibiotics.50.201","article-title":"Production of brominated tiacumicin derivatives","volume":"50","author":"Hochlowski","year":"1997","journal-title":"J Antibiot"},{"key":"10.1016\/j.mib.2011.07.030_bib0405_1","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/cbic.201100129","article-title":"Characterization of a sugar-O-methyltransferase TiaS5 affords new tiacumicin analogues with improved antibacterial properties and reveals substrate promiscuity","volume":"12","author":"Niu","year":"2011","journal-title":"Chembiochem"},{"key":"10.1016\/j.mib.2011.07.030_bib0365","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ab.2003.08.038","article-title":"A fluorescence-based assay for multisubunit DNA-dependent RNA polymerases","volume":"324","author":"Kuhlman","year":"2004","journal-title":"Anal Biochem"},{"key":"10.1016\/j.mib.2011.07.030_bib0370","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1016\/0167-7012(89)90018-3","article-title":"Application of the spiral plating method to study antimicrobial action","volume":"10","author":"Wallace","year":"1989","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.mib.2011.07.030_bib0375","first-page":"31","article-title":"Measurement of MICs of antibacterial agents by spiral gradient endpoint compared with conventional dilution methods","volume":"3","author":"Paton","year":"1990","journal-title":"Int J Exp Clin Chemother"},{"key":"10.1016\/j.mib.2011.07.030_bib0380","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-4757-9206-5_10","article-title":"Measures of susceptibility from a spiral gradient of drug concentrations","volume":"349","author":"Schalkowsky","year":"1994","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.mib.2011.07.030_bib0385","series-title":"Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard","author":"Clinical and Laboratory Standards Institute (CLSI\/NCCLS)","year":"2009"},{"key":"10.1016\/j.mib.2011.07.030_bib0390","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/AAC.41.5.1004","article-title":"Microplate Alamar Blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium","volume":"41","author":"Collins","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mib.2011.07.030_bib0395","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard","author":"Clinical and Laboratory Standards Institute (CLSI\/NCCLS)","year":"2009"}],"container-title":["Current Opinion in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369527411001147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369527411001147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T13:19:50Z","timestamp":1592831990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1369527411001147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":77,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1369527411001147"],"URL":"https:\/\/doi.org\/10.1016\/j.mib.2011.07.030","relation":{},"ISSN":["1369-5274"],"issn-type":[{"value":"1369-5274","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}